DIN 02493551 — IBRANCE 125 MG
IBRANCE is a tablet of Palbociclib marketed by PFIZER CANADA ULC. The full Palbociclib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02493551
- Brand name
- IBRANCE
- Active ingredient
- Palbociclib
- Strength
- 125 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (CDK4/6 inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Palbociclib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02493543 | IBRANCE | 100 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02493535 | IBRANCE | 75 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02552132 | PMS-PALBOCICLIB | 100 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02552140 | PMS-PALBOCICLIB | 125 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02552124 | PMS-PALBOCICLIB | 75 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02547643 | TARO-PALBOCICLIB | 100 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02547651 | TARO-PALBOCICLIB | 125 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02547635 | TARO-PALBOCICLIB | 75 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |